Top

Published in:

01-06-2018 | Original Research

Psychosocial Implications of Living with Catecholaminergic Polymorphic Ventricular Tachycardia in Adulthood

Authors: Ebony Richardson, Catherine Spinks, Andrew Davis, Christian Turner, John Atherton, Julie McGaughran, Christopher Semsarian, Jodie Ingles

Published in: Journal of Genetic Counseling | Issue 3/2018

Abstract

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare inherited arrhythmogenic disease with a high risk of sudden cardiac death. The impact on health-related quality of life (HR-QoL) and psychosocial outcomes is not known. We sought to provide the first description of HR-QoL and psychosocial wellbeing of adults with CPVT, parents of affected children and at-risk relatives. Participants were recruited through the Australian Genetic Heart Disease Registry and invited to complete a cross-sectional survey comprising a number of validated scales and open-ended questions. Thirty-five participants completed surveys (response rate 65%), including 19 with CPVT, 10 unaffected parents of a child with CPVT, and 7 at-risk relatives (one participant considered patient and parent). Young patients <40 years were significantly more likely to report anxiety (p = 0.04), depression (p = 0.03) and posttraumatic stress symptoms (p = 0.02) compared to older CPVT patients. Further, young patients with an implantable cardioverter defibrillator (ICD) reported significantly worse device-related distress (p = 0.04) and shock anxiety (p = 0.003). Patients with a genetic diagnosis had worse psychological adaptation than those patients without a gene result. Parents perceived their affected children to have poor quality of life across all subdomains compared to healthy age-matched children, however quality of life of parents and at-risk relatives was comparable to population norms. Ongoing psychosocial care is required for young people with CPVT. Those with an ICD and/or undergoing genetic testing may require additional support. The challenges of CPVT management should extend beyond the clinical and genetic aspects of care to incorporate greater psychosocial support, and further reinforces the need for a multidisciplinary approach to care.

Ackerman, M. J., Priori, S. G., Willems, S., Berul, C., Brugada, R., Calkins, H., et al. (2011). HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm, 8(8), 1308–1339. https://doi.org/10.1016/j.hrthm.2011.05.020.CrossRefPubMed

Burns, J. L., Serber, E. R., Keim, S., & Sears, S. F. (2005). Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey. Journal of Cardiovascular Electrophysiology, 16(4), 384–390. https://doi.org/10.1046/j.1540-8167.2005.40134.x.CrossRefPubMed

Caleshu, C., Kasparian, N. A., Edwards, K. S., Yeates, L., Semsarian, C., Perez, M., et al. (2016). Interdisciplinary psychosocial care for families with inherited cardiovascular diseases. Trends in Cardiovascular Medicine. https://doi.org/10.1016/j.tcm.2016.04.010.

Cheung, C. C., Laksman, Z. W., Mellor, G., Sanatani, S., & Krahn, A. D. (2016). Exercise and Inherited Arrhythmias. The Canadian Journal of Cardiology, 32(4), 452–458. https://doi.org/10.1016/j.cjca.2016.01.007.CrossRefPubMed

Christiaans, I., van Langen, I. M., Birnie, E., Bonsel, G. J., Wilde, A. A., & Smets, E. M. (2009). Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. American Journal of Medical Genetics Part A, 149A(4), 602–612. https://doi.org/10.1002/ajmg.a.32710.CrossRefPubMed

Cox, S., O'Donoghue, A. C., McKenna, W. J., & Steptoe, A. (1997). Health related quality of life and psychological wellbeing in patients with hypertrophic cardiomyopathy. Heart, 78(2), 182–187.CrossRefPubMedPubMedCentral

Czosek, R. J., Cassedy, A. E., Wray, J., Wernovsky, G., Newburger, J. W., Mussatto, K. A., et al. (2015). Quality of life in pediatric patients affected by electrophysiologic disease. Heart Rhythm, 12(5), 899–908. https://doi.org/10.1016/j.hrthm.2015.01.022.CrossRefPubMed

Hamang, A., Eide, G. E., Nordin, K., Rokne, B., Bjorvatn, C., & Oyen, N. (2010). Health status in patients at risk of inherited arrhythmias and sudden unexpected death compared to the general population. BMC Medical Genetics, 11, 27. https://doi.org/10.1186/1471-2350-11-27.CrossRefPubMedPubMedCentral

Hawthorne, G., Osborne, R., Taylor, A., & Sansoni, J. (2007). The SF36 version 2: critical analyses of population weights, scoring algorithms and population norms. Quality of Life Research, 16(4), 661–673.CrossRefPubMed

Hayashi, M., Denjoy, I., Extramiana, F., Maltret, A., Buisson, N. R., Lupoglazoff, J. M., et al. (2009). Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation, 119(18), 2426–2434. https://doi.org/10.1161/circulationaha.108.829267.CrossRefPubMed

Hendriks, K. S., Grosfeld, F. J., van Tintelen, J. P., van Langen, I. M., Wilde, A. A., van den Bout, J., & ten Kroode, H. F. (2005). Can parents adjust to the idea that their child is at risk for a sudden death?: Psychological impact of risk for long QT syndrome. American journal of medical genetics. Part A, 138A(2), 107–112. https://doi.org/10.1002/ajmg.a.30861.

Hendriks, K. S., Hendriks, M. M., Birnie, E., Grosfeld, F. J., Wilde, A. A., van den Bout, J., … van Langen, I. M. (2008). Familial disease with a risk of sudden death: a longitudinal study of the psychological consequences of predictive testing for long QT syndrome. Heart Rhythm, 5(5), 719–724. doi:S1547–5271(08)00117–3.

Ingles, J., & Semsarian, C. (2013). The Australian genetic heart disease registry. International Journal of Cardiology, 168(4), e127–e128. https://doi.org/10.1016/j.ijcard.2013.08.036.CrossRefPubMed

Ingles, J., Yeates, L., & Semsarian, C. (2011). The emerging role of the cardiac genetic counselor. Heart Rhythm, 8(12), 1958–1962.CrossRefPubMed

Ingles, J., Sarina, T., Kasparian, N., & Semsarian, C. (2013a). Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. International Journal of Cardiology, 168(4), 3779–3784. https://doi.org/10.1016/j.ijcard.2013.06.006.CrossRefPubMed

Ingles, J., Yeates, L., Hunt, L., McGaughran, J., Scuffham, P. A., Atherton, J., & Semsarian, C. (2013b). Health status of cardiac genetic disease patients and their at-risk relatives. International Journal of Cardiology, 165(3), 448–453. https://doi.org/10.1016/j.ijcard.2011.08.083.CrossRefPubMed

Ingles, J., Spinks, C., Yeates, L., McGeechan, K., Kasparian, N., & Semsarian, C. (2016). Posttraumatic Stress and Prolonged Grief After the Sudden Cardiac Death of a Young Relative. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2015.7808.

Jabbari, J., Jabbari, R., Nielsen, M. W., Holst, A. G., Nielsen, J. B., Haunso, S., et al. (2013). New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia. Circulation. Cardiovascular Genetics, 6(5), 481–489. https://doi.org/10.1161/circgenetics.113.000118.CrossRefPubMed

James, C. A., Tichnell, C., Murray, B., Daly, A., Sears, S. F., & Calkins, H. (2012). General and disease-specific psychosocial adjustment in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy with implantable cardioverter defibrillators: a large cohort study. Circulation. Cardiovascular Genetics, 5(1), 18–24. https://doi.org/10.1161/CIRCGENETICS.111.960898.CrossRefPubMed

Kozlovski, J., Ingles, J., Connell, V., Hunt, L., McGaughran, J., Turner, C., et al. (2014). Delay to diagnosis amongst patients with catecholaminergic polymorphic ventricular tachycardia. International Journal of Cardiology, 176(3), 1402–1404. https://doi.org/10.1016/j.ijcard.2014.08.020.CrossRefPubMed

Kuhl, E. A., Dixit, N. K., Walker, R. L., Conti, J. B., & Sears, S. F. (2006). Measurement of patient fears about implantable cardioverter defibrillator shock: an initial evaluation of the Florida Shock Anxiety Scale. Pacing and Clinical Electrophysiology, 29(6), 614–618. https://doi.org/10.1111/j.1540-8159.2006.00408.x.CrossRefPubMed

Lampert, R., Olshansky, B., Heidbuchel, H., Lawless, C., Saarel, E., Ackerman, M., et al. (2013). Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry. Circulation, 127(20), 2021–2030. https://doi.org/10.1161/CIRCULATIONAHA.112.000447.CrossRefPubMed

Leenhardt, A., Denjoy, I., & Guicheney, P. (2012). Catecholaminergic polymorphic ventricular tachycardia. Circulation. Arrhythmia and Electrophysiology, 5(5), 1044–1052. https://doi.org/10.1161/circep.111.962027.CrossRefPubMed

Marin, T., Taylor, A., & Gill, T. (2009). Population Profile of Quality of Life in South Australia - Population Norms for 2008 using the SF36 Version 2. Population Research and Outcomes Studies Unit. Adelaide: South Australian Department of Health.

Maron, B. J., Chaitman, B. R., Ackerman, M. J., Bayes de Luna, A., Corrado, D., Crosson, J. E., et al. (2004). Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation, 109(22), 2807–2816. https://doi.org/10.1161/01.CIR.0000128363.85581.E1.CrossRefPubMed

Napolitano, C., Priori, S. G., & Bloise, R. (1993). Catecholaminergic Polymorphic Ventricular Tachycardia. In R. A. Pagon, M. P. Adam, H. H. Ardinger, S. E. Wallace, A. Amemiya, L. J. H. Bean, T. D. Bird, N. Ledbetter, H. C. Mefford, R. J. H. Smith, & K. Stephens (Eds.), GeneReviews(R). Seattle: University of Washington.

Ostby, S. A., Bos, J. M., Owen, H. J., Wackel, P. L., Cannon, B. C., & Ackerman, M. J. (2016). Competitive sports participation in patients with catecholaminergic polymorphic ventricular tachycardia. A single center's early experience. JACC Electrophysiology, 2(3), 253–262.CrossRef

Priori, S. G., Napolitano, C., Memmi, M., Colombi, B., Drago, F., Gasparini, M., et al. (2002). Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation, 106(1), 69–74.CrossRefPubMed

Priori, S. G., Blomstrom-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., et al. (2015). 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). European Heart Journal, 36(41), 2793–2867. https://doi.org/10.1093/eurheartj/ehv316.CrossRefPubMed

Read, C. Y., Perry, D. J., & Duffy, M. E. (2005). Design and psychometric evaluation of the Psychological Adaptation to Genetic Information Scale. Journal of Nursing Scholarship, 37(3), 203–208.CrossRefPubMed

Schwartz, P. J., Ackerman, M. J., George Jr., A. L., & Wilde, A. A. (2013). Impact of genetics on the clinical management of channelopathies. Journal of the American College of Cardiology, 62(3), 169–180. https://doi.org/10.1016/j.jacc.2013.04.044.CrossRefPubMedPubMedCentral

van der Werf, C., Onderwater, A. T., van Langen, I. M., & Smets, E. M. (2014). Experiences, considerations and emotions relating to cardiogenetic evaluation in relatives of young sudden cardiac death victims. European Journal of Human Genetics, 22(2), 192–196. https://doi.org/10.1038/ejhg.2013.126.CrossRefPubMed

Varni, J. W., Seid, M., & Rode, C. A. (1999). The PedsQL: measurement model for the pediatric quality of life inventory. Medical Care, 37(2), 126–139.CrossRefPubMed

Vazquez, L. D., Conti, J. B., & Sears, S. F. (2010). Female-specific education, management, and lifestyle enhancement for implantable cardioverter defibrillator patients: the FEMALE-ICD study. Pacing and Clinical Electrophysiology, 33(9), 1131–1140. https://doi.org/10.1111/j.1540-8159.2010.02787.x.CrossRefPubMed

Ware Jr., J. E., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care, 30(6), 473–483.PubMed

Weiss, D., & Marmar, C. (1997). The Impact of Event Scale-Revised. New York: The Guilford Press.

Zigmond, A., & Snaith, R. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, (67), 361–370.

Title: Psychosocial Implications of Living with Catecholaminergic Polymorphic Ventricular Tachycardia in Adulthood
Authors: Ebony Richardson
Catherine Spinks
Andrew Davis
Christian Turner
John Atherton
Julie McGaughran
Christopher Semsarian
Jodie Ingles
Publication date: 01-06-2018
Publisher: Springer US
Published in: Journal of Genetic Counseling / Issue 3/2018
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-017-0152-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Psychosocial Implications of Living with Catecholaminergic Polymorphic Ventricular Tachycardia in Adulthood

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2018

Patients’ Opinions on Genetic Counseling on the Increased Risk of Parkinson Disease among Gaucher Disease Carriers

The Genetic Counselor in the Pediatric Arrhythmia Clinic: Review and Assessment of Services

Talking with Children About Adult-Onset Hereditary Cancer Risk: A Developmental Approach for Parents

Psychosocial Distress and Knowledge Deficiencies in Parents of Children in Ireland Who Carry an Altered Cystic Fibrosis Gene

“Where Does it Come from?” Experiences Among Survivors and Parents of Children with Retinoblastoma in Kenya

Assessment of Current Genetic Counselor Practices in Post-Visit Written Communications to Patients